Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Files for Download
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946014/pdf/ciw256.pdf
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
Voir les documents
Titre
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus
Sujet
Description
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States.
Date
2016-08-01
Type
Citer ce document
Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki (2016). "Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus." Clin Infect Dis 63(3): 376-379.
Résumé
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.
Accessibilité
free online - Pubmed Central
Was this resource helpful?